Endocrine Therapy in Breast Cancer: Making Sense of the ‘Word Salad’
About 80 percent of breast cancers express the estrogen receptor (ER). In ER-positive tumors, estrogen is the main driver...
Tag: SABCS
About 80 percent of breast cancers express the estrogen receptor (ER). In ER-positive tumors, estrogen is the main driver...
Next-generation genome analysis technologies allow for the sequencing of multiple genes at once to characterize the mutational profile of...
As recently as 10 years ago, the words “machine learning” evoked thoughts of sentient robots and fears of the...
Surrounding a tumor is a vast network of blood vessels, immune cells, proteins, and even bacteria, all of which...
Triple-negative breast cancer (TNBC) is aggressive, with high risk of metastasis and recurrence, and is challenging to treat due to a lack of effective targeted therapies. However, a higher...
Thirty years ago, Mary-Claire King, PhD, FAACR, and colleagues were the first to demonstrate that breast cancer could be genetically inherited....
Several options are available for the treatment of breast cancer, including local therapies such as surgery and radiation therapy,...
As we approach the end of the year that was consumed by the pandemic, more than 68 million people...
Editor’s note: When the San Antonio Breast Cancer Symposium (SABCS) kicks off next week, researchers will present the results...
Breast cancer can be a scary diagnosis. Even though mortality rates have declined in recent years in the United...